Propofol for laryngospasm

Low dose propofol versus lidocaine for relief of resistant post-extubation laryngospasm in the obstetric patient

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201607001643276

Enrollment

Registered

2016-05-19

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Laryngospasm

Interventions

propofol

Lidocaine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All parturients of ASA class I or II, who were scheduled for cesarean section under general anesthesia, suffered from post-extubation laryngospasm.

Exclusion criteria

Exclusion criteria: known sensitivity to lidocaine or propofol upper respiratory tract infection history of bronchial asthma or other lung diseases chronic smoking chronic exposure to smokers, dust or fumes.

Design outcomes

Primary

Measure	Time frame
relief of laryngospasm	—

Secondary

Measure	Time frame
incidence of complications (gastric distension, aspiration, NPPE, arrhythmias, or cardiac arrest)	—

Countries

Egypt

Contacts

Public ContactAli Mokhtar

Lecturer of Anesthesia, Cairo university.

alyaly4444@gmail.com01114999890

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026